<unk>  (EU/NETE) is a combination medication of estradiol<unk>  (EU), an estrogen, and norethisterone<unk>  (NETE), a progestin, which was developed by Schering for potential use as a combined injectable contraceptive in women but was ultimately never marketed. It contained 5 to 10 mg EU and 50 to 70 mg NETE in oil solution and was intended for use by intramuscular injection at regular intervals. Although never commercialized, EU/NETE was found to be effective and well tolerated.
Estradiol undecylate/norethisterone enanthate
Estradiol enantate/algestone acetophenide
Estradiol/norethisterone acetate
Estradiol valerate/norethisterone enantate
Relugolix/estradiol/norethisterone acetate
Elagolix/estradiol/norethindrone acetate
Estradiol valerate/prasterone enanthate
Mestranol/norethisterone